Primary Amyloidosis Clinical Trials

Find Primary Amyloidosis Clinical Trials Near You

BE.Amycon Biobank & Data Registry UZ Leuven: Human Body Material (HBM) Collection and Data Collection of Patients With Amyloidosis

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank BE.Amycon biobank for future research and to collect clinical data of patients with amyloidosis in a database BE.Amycon data registry.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Provide consent and sign informed consent form

• Age 18 years or older

• Diagnosis of amyloidosis (suspected or confirmed, any subtypes)

• For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis)

Locations
Other Locations
Belgium
UZ Leuven Gasthuisberg - cardiology
RECRUITING
Leuven
UZ Leuven Gasthuisberg - hematology
RECRUITING
Leuven
Contact Information
Primary
Michel Delforge
michel.delforge@uzleuven.be
+32 16 346880
Time Frame
Start Date: 2025-09-24
Estimated Completion Date: 2030-01
Participants
Target number of participants: 505
Sponsors
Leads: Universitaire Ziekenhuizen KU Leuven
Collaborators: Vlaams Instituut voor Biotechnologie

This content was sourced from clinicaltrials.gov

Similar Clinical Trials